Phosphodiesterase Inhibitors 1996
DOI: 10.1016/b978-012210720-7/50005-8
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Theophylline and Non-selective Xanthine Derivatives on PDE Isoenzymes and Cellular Function

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
4
0

Year Published

1998
1998
2011
2011

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 181 publications
1
4
0
Order By: Relevance
“…Our ®nding that YC-1 is a novel PDE inhibitor con®rms and extends the results of a recent study that suggested YC-1 inhibited cyclic AMP break down in myocardium (Wegener et al, 1997). YC-1 does not show structural similarity to any known PDE inhibitor; however, its potency is low, ranging between the non-selective PDE inhibitors 3-isobutyl-1-methylxanthine (IBMX) and theophylline (Dent & Rabe, 1996). Low potency, together with its low selectivity, make YC-1, however, an unattractive lead compound for further development of related PDE inhibitors.…”
Section: Discussionsupporting
confidence: 58%
“…Our ®nding that YC-1 is a novel PDE inhibitor con®rms and extends the results of a recent study that suggested YC-1 inhibited cyclic AMP break down in myocardium (Wegener et al, 1997). YC-1 does not show structural similarity to any known PDE inhibitor; however, its potency is low, ranging between the non-selective PDE inhibitors 3-isobutyl-1-methylxanthine (IBMX) and theophylline (Dent & Rabe, 1996). Low potency, together with its low selectivity, make YC-1, however, an unattractive lead compound for further development of related PDE inhibitors.…”
Section: Discussionsupporting
confidence: 58%
“…Figures represent the values of IC 50 (μM) for each inhibitor reported previously. Superscript letters represent references(:) a, Beavo (1995); b, Loughney et al (1998); c, Kotera et al (2000a); d, Dent and Rabe (1996); e, Murray (1993); f, Hetman et al (2000); g, Soderling et al (1998); h, Fisher et al (1998); i, Fujishige et al (1999); j, Fawcett et al (2000); k, Yuasa et al (2000).…”
Section: Discussionmentioning
confidence: 99%
“…[10,11] It has also been shown that cAMP phosphodiesterase inhibitors suppress the production of pro-inflammatory cytokines such as TNF-a, IL-2 and interferon g, and stimulate the anti-inflammatory cytokine IL-10. [12,13] In animal studies, it has been shown that long-term dietary supplementation with caffeine or coffee suppresses LPS induced elevation of serum AST and ALT levels in D-galactosamine (D-GalN) sensitised rats. [14,15] In the present study, we investigated the effects of caffeine with single-time administration on LPS/D-GalN induced acute liver injury in rats, by examining survival rates and plasma AST, ALT, TNF-a and IL-10 levels.…”
Section: Introductionmentioning
confidence: 99%